Search
for
Sort by
Research 181–210 of 302
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Animal models of androgen-dependent disorders of the pilosebaceous apparatus
- A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
- Serum Iron, Zinc, and Copper Concentration in Premature Graying of Hair
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Effect of cyclosporin on hair-existing area of nude mice
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Inflammatory auxo-action in the stem cell division theory of cancer
- SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- A Portable Electrospinner for Nanofiber Synthesis and Its Application for Cosmetic Treatment of Alopecia
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Janus kinase inhibitors for alopecia areata
- Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
- Alopecia areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Janus kinase inhibitors for alopecia areata: A narrative review